Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Latest filing published 26 May 2026 for Beta Bionics, Inc.. Read the official filing
Filing timeline
BuySaleDanny L. Dearen
Insider track record
Disclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Danny L. Dearen: trading record in brief
Danny L. Dearen is a declared insider at 3 companies (chief executive); the most frequent names are Axonics, Inc., Beta Bionics, Inc. and InspireMD, Inc. We count 20 filings; the first trade dates from 20 May 2021 and the latest from 21 May 2026.
No open-market purchase appears, only 4 sales worth €1.5M. Other entries cover 5 share grants and 11 option exercises.
The latest filing, published on 26 May 2026, reports a share grant in Beta Bionics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 4 days. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Danny L. Dearen
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations20 total
16,965 shares0Common StockSEC:0001756438-26-000003:0
44,030 shares0Common StockSEC:0001493152-26-002664:0
3,997 shares0Common StockSEC:0001756438-26-000002:0
11,247 shares0Common StockSEC:0001415889-25-008535:0
36,919 shares0Common StockSEC:0001562180-23-007189:0
11,250 shares0Common StockSEC:0001562180-23-007190:0
7,699 shares@ US$49.43559.7% of flowCommon StockSEC:0001562180-23-004641:0
13,208 shares@ US$14.194.7% of flowCommon StockSEC:0001562180-23-003685:0
10,363 shares@ US$59.930815.5% of flowCommon StockSEC:0001562180-23-003685:1
9,637 shares@ US$60.503714.6% of flowCommon StockSEC:0001562180-23-003685:2
2,001 shares@ US$14.190.7% of flowCommon StockSEC:0001562180-23-003669:0
6,633 shares@ US$14.192.4% of flowCommon StockSEC:0001562180-23-003425:0
5,000 shares0Common StockSEC:0001562180-23-000874:0
656 shares@ US$75.601.4% of flowCommon StockSEC:0001562180-22-006685:0
1,616 shares@ US$1.320.1% of flowCommon StockSEC:0001562180-22-006102:0
12,329 shares@ US$25.8215.2% of flowCommon StockSEC:0001562180-22-002348:0
6,421 shares@ US$25.825.0% of flowCommon StockSEC:0001562180-22-002063:0
20,000 shares@ US$14.198.6% of flowCommon StockSEC:0001562180-22-001105:0
10,805 shares@ US$14.194.6% of flowCommon StockSEC:0001562180-22-000563:0
28,291 shares@ US$14.1911.2% of flowCommon StockSEC:0001562180-21-003716:0
20 of 20 declarations
